Dosidal · Switzerland
Xarelto junior, Granulat zur Herstellung einer Suspension zum Einnehmen
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:67701 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 67701 atc: B01AF01 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2021-06-02 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: B01AF01 authorisation_number: 67701 form: GRAS holder: Bayer (Schweiz) AG holder_partner_nr: 1000372 it_number: 06.03.0. name: Xarelto junior, Granulat zur Herstellung einer Suspension zum Einnehmen state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53thh0r2z2WnqzFPCeYZ_YiWeqS2wmNPeZ-FFjBUxwb-6iiy_kmJmNtS5x1m2fkWrU8Vwdvnya18Uz0n_WYa7-WwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |